⌘K
CaaS Capital
Deals on record
1
Common Fundraising Type
Series C
Umoja Biopharma
Biotechnology • In vivo cell therapies
Umoja Biopharma is a biotechnology company focused on developing in vivo CAR T cell therapies for oncology and autoimmune diseases using its VivoVec™ gene delivery technology.